Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stacchiotti S"'
Autor:
Pasquali, S., Pizzamiglio, S., Touati, N., Litiere, S., Marreaud, S., Kasper, B., Gelderblom, H., Stacchiotti, S., Judson, I., Tos, A.P. dei, Verderio, P., Casali, P.G., Woll, P.J., Gronchi, A., EORTC Soft Tissue Bone Sarcoma Grp
Publikováno v:
European Journal of Cancer, 109, 51-60. ELSEVIER SCI LTD
Background: This study was aimed at determining whether patients with high-risk soft tissue sarcoma (STS), as identified using the nomogram Sarculator, benefitted from adjuvant chemotherapy in the EORTC-STBSG 62931 randomised controlled trial (RCT),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55379815bffee4183aa2fb368e92404
http://hdl.handle.net/11577/3288507
http://hdl.handle.net/11577/3288507
Autor:
Stacchiotti, S., Saponara, M., Frapolli, R., Tortoreto, M., Cominetti, D., Provenzano, S., Negri, T., Dagrada, G. P., Gronchi, A., Colombo, C., Vincenzi, B., Badalamenti, G., Zuco, V., Renne, S. L., Collini, P., Morosi, C., Dei Tos, A. P., Bello, E., Pilotti, S., Casali, P. G., D'Incalci, M., Zaffaroni, N., BADALAMENTI, Giuseppe
Background Preclinical models that mimic pathological and molecular features of solitary fibrous tumour (SFT) represent an important tool to select effective regimes and novel compounds to be tested in the clinic. This study was aimed at developing t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::684d10b3b44f5cc23769ec1dfd31843b
http://hdl.handle.net/11577/3243721
http://hdl.handle.net/11577/3243721
Autor:
Urbini, M, Astolfi, A, Pantaleo, Ma, Serravalle, S, DEI TOS, Angelo, Picci, P, Indio, V, Sbaraglia, M, Benini, S, Righi, A, Gambarotti, M, Gronchi, A, Colombo, Claudia, Dagrada, Gp, Pilotti, S, Maestro, R, Polano, M, Saponara, M, Tarantino, G, Pession, A, Biasco, G, Casali, Pg, Stacchiotti, S.
Extraskeletal myxoid chondrosarcoma (EMC) is a very rare sarcoma most often arising in the soft tissue. Rare EMC of the bone have been reported. EMC exhibits distinctive clinico-pathological and genetic features; however, despite the name, it lacks a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::574325281dc86c076397141a6cb8fd6d
http://hdl.handle.net/11585/610754
http://hdl.handle.net/11585/610754
Autor:
Marco Fiore, Silvia Stacchiotti, Anna Maria Frezza, Marta Barisella, Stefano Radaelli, Alberto Righi, Anna Paioli, Giovanni Beltrami, Giuseppe Bianchi, Emanuela Palmerini, Piero Picci, Domenico Andrea Campanacci, Alessandro Gronchi, Stefania Benini, Alessandra Longhi, Davide Maria Donati
Publikováno v:
Annals of Surgical Oncology. 28:1142-1150
Background: Extraskeletal myxoid chondrosarcoma (EMC) is a rare sarcoma of uncertain origin, marked by specific chromosomal translocations involving the NR4A3 gene, and usually characterized by an indolent course. Surgery (with or without radiotherap
Autor:
Michiel A. J. van de Sande, Andrew J. Hayes, Elizabeth H. Baldini, Jay S. Wunder, Augustinus D.G. Krol, Silvia Stacchiotti, Laura De Rosa, Anthony M. Griffin, Peter C. Ferguson, Jacus Skoczylas, Winan J. van Houdt, Chandrajit P. Raut, Dirk C. Strauss, Estelle Lecointe-Artzner, Iris Walraven, Yvonne Schrage, Claudia Sangalli, Mark Fairweather, Rick L. Haas, Alessandro Gronchi
Publikováno v:
Cancer, 126(13), 3002-3012. WILEY
Cancer, 126, 13, pp. 3002-3012
Cancer, 126(13), 3002-3012. Wiley
Cancer
Cancer, 126, 3002-3012
Cancer, 126, 13, pp. 3002-3012
Cancer, 126(13), 3002-3012. Wiley
Cancer
Cancer, 126, 3002-3012
Background Solitary fibrous tumor (SFT) is a rare mesenchymal malignancy. Although surgery is potentially curative, the local relapse risk is high after marginal resections. Given the lack of prospective clinical trial data, the objective of the curr
Autor:
Giovanni Grignani, Emanuela Marchesi, Carlo Morosi, Piero Picci, Robert Diaz Beveridge, Silvia Bagué, Paolo Bruzzi, Virginia Ferraresi, Davide Maria Donati, Angelo Paolo Dei Tos, Antonio López Pousa, Giuseppe Bianchi, Paolo G. Casali, Silvia Stacchiotti, Iwona Lugowska, Antonella Brunello, Jean Michel Coindre, Javier Martin Broto, Oscar Tendero, Emanuela Palmerini, Jean-Yves Blay, Elena Palassini, Luca Braglia, Valeria Fontana, Domenico Franco Merlo, Alessandro Gronchi, Andrea Marrari, Vittorio Quagliuolo
Publikováno v:
JOURNAL OF CLINICAL ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Digital.CSIC. Repositorio Institucional del CSIC
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Digital.CSIC. Repositorio Institucional del CSIC
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
[Purpose] To determine whether the administration of histology-tailored neoadjuvant chemotherapy (HT) was superior to the administration of standard anthracycline plus ifosfamide neoadjuvant chemotherapy (A+I) in high-risk soft tissue sarcoma (STS) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ae2e6c7c0dd5bcce7d0c3bbfa053d6
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1808
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1808
Autor:
Alexandra Meurgey, Paolo G. Casali, Katherine Thornton, Scott M. Schuetze, Maria Abbondanza Pantaleo, Jean-Yves Blay, Marta Sbaraglia, Salvatore Lo Vullo, Tarek Assi, Paweł Teterycz, Robert G. Maki, Hans Gelderblom, Anna Maria Frezza, Robin L. Jones, Jason L. Hornick, Olivier Mir, Eytan Ben-Ami, Silvia Stacchiotti, Axel Le Cesne, Vinod Ravi, Luigi Mariani, Ingrid M.E. Desar, Alexander Fedenko, Anna M. Czarnecka, Florence Duffaud, Andrew J. Wagner, Richard Ferraro, Akira Kawai, Emi Noguchi, Brittany Siontis, Robert S. Benjamin, Bruno Vincenzi, Alessandro Gronchi, Giacomo Giulio Baldi, Mrinal M. Gounder, Armelle Dufresne, Julien Adam, Kan Yonemori, Marta Barisella
Publikováno v:
Cancer, 126, 1, pp. 98-104
Cancer, 126, 98-104
Cancer
Cancer. WILEY
Cancer, 126, 98-104
Cancer
Cancer. WILEY
Contains fulltext : 220839.pdf (Publisher’s version ) (Closed access) BACKGROUND: Intimal sarcoma (InS) is an exceedingly rare neoplasm with an unfavorable prognosis, for which new potentially active treatments are under development. We report on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be658f0d6087906fb37344e619ca0e8
https://hdl.handle.net/2066/220839
https://hdl.handle.net/2066/220839
Autor:
Monique J L Mastboom, Emanuela Palmerini, Floortje G M Verspoor, Anja J Rueten-Budde, Silvia Stacchiotti, Eric L Staals, Gerard R Schaap, Paul C Jutte, Will Aston, Hans Gelderblom, Andreas Leithner, Dietmar Dammerer, Akihiko Takeuchi, Quirina Thio, Xiaohui Niu, Jay S Wunder, Michiel A J van de Sande, M. Fiocco, P.D.S. Dijkstra, R.J.P. Van der Wal, P.A. Daolio, P. Picci, A. Gronchi, S. Ferrari, H. Özger, R.G. Maki, H.W.B. Schreuder, I.C.M. Van der Geest, J.A.M. Bramer, W.J.B. Mastboom, M. Boffano, E. Goldenitsch, D. Campanacci, P. Cuomo, P.C. Ferguson, A.M. Griffin, Y. Sun, T. Schubert, K. Patel, M.S.J. Aranguren, A. Blancheton, F. Gouin, H.R. Dürr, C.F. Capellen, J. Schwab, S. Iwata, O. Vyrva, W. Weschenfelder, E.H.M. Wang, M. Wook Joo, Y.K. Kang, Y.G. Chung, W. Ebeid, J. Bruns, T. Ueda
Publikováno v:
The Lancet Oncology, 20(6), 877-886. ELSEVIER SCIENCE INC
Lancet Oncology, 20(6), 877-886. ELSEVIER SCIENCE INC
Mastboom, M J L, Palmerini, E, Verspoor, F G M, Rueten-Budde, A J, Stacchiotti, S, Staals, E L, Schaap, G R, Jutte, P C, Aston, W, Gelderblom, H, Leithner, A, Dammerer, D, Takeuchi, A, Thio, Q, Niu, X, Wunder, J S, TGCT Study Group & van de Sande, M A J 2019, ' Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study ', The Lancet Oncology, vol. 20, no. 6, pp. 877-886 . https://doi.org/10.1016/S1470-2045(19)30100-7
Lancet Oncology, 20, 877-886
Lancet Oncology, 20, 6, pp. 877-886
lancet oncology, 20(6), 877-886. Lancet Publishing Group
The Lancet Oncology, 20(6), 877-886. Lancet Publishing Group
Lancet Oncology, 20(6), 877-886. ELSEVIER SCIENCE INC
Mastboom, M J L, Palmerini, E, Verspoor, F G M, Rueten-Budde, A J, Stacchiotti, S, Staals, E L, Schaap, G R, Jutte, P C, Aston, W, Gelderblom, H, Leithner, A, Dammerer, D, Takeuchi, A, Thio, Q, Niu, X, Wunder, J S, TGCT Study Group & van de Sande, M A J 2019, ' Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study ', The Lancet Oncology, vol. 20, no. 6, pp. 877-886 . https://doi.org/10.1016/S1470-2045(19)30100-7
Lancet Oncology, 20, 877-886
Lancet Oncology, 20, 6, pp. 877-886
lancet oncology, 20(6), 877-886. Lancet Publishing Group
The Lancet Oncology, 20(6), 877-886. Lancet Publishing Group
Contains fulltext : 208201.pdf (Publisher’s version ) (Closed access) BACKGROUND: Diffuse-type tenosynovial giant-cell tumour is a rare, locally aggressive, and difficult-to-treat soft tissue tumour. Clinical and surgical outcomes depend on multipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60bdbfc5ddda1ea4ea3aa3697189ae9
http://hdl.handle.net/1887/121939
http://hdl.handle.net/1887/121939
Autor:
Paola Collini, Silvia Brich, Milijana Janjusevic, Gianpaolo Dagrada, Marta Sbaraglia, Maurizio Polano, Angelo Paolo Dei Tos, Sabrina Rossi, Valentina Indio, Dominga Racanelli, Kelly Fassetta, Silvia Stacchiotti, Monica Brenca, Roberta Maestro, Chiara Colombo, Piero Picci, Silvana Pilotti, Annalisa Astolfi, Paolo G. Casali, Maria Abbondanza Pantaleo, Alessandro Gronchi
Publikováno v:
J Pathol
The Journal of Pathology
The Journal of Pathology
Extraskeletal myxoid chondrosarcoma (EMC) is a rare sarcoma histotype with uncertain differentiation. EMC is hallmarked by the rearrangement of the NR4A3 gene, which in most cases fuses with EWSR1 or TAF15. TAF15‐translocated EMC seem to feature a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d840b4720a876ef126cda86df448dec9
http://hdl.handle.net/11392/2411059
http://hdl.handle.net/11392/2411059
Autor:
A. Lecesne, Dominga Racanelli, Jean-Yves Blay, Anna Maria Frezza, Marie Karanian, Silvia Brich, Daniel Bernabeu, Antonio Lopez-Pousa, María Ángeles Vaz Salgado, Paolo G. Casali, Sarah Dumont, Silvia Stacchiotti, Carlo Morosi, Chiara Castelli, Josefina Cruz, Monica Brenca, Antonio Gutierrez, Giovanni Grignani, Roberta Maestro, Nicolas Penel, Stefano Ferrari, Nadia Hindi, Andrés Redondo, Gianpaolo Dagrada, Javier Martin-Broto, Emanuela Palmerini, Paola Collini, Enrique de Álava, Antoine Italiano, Viviana Vallacchi
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Background] Extraskeletal myxoid chondrosarcoma is a rare sarcoma with low sensitivity to cytotoxic chemotherapy. Retrospective evidence suggests that antiangiogenic drugs could be a treatment option. We aimed to investigate the activity of pazopani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204a7733c1d12dab1b43434c781c5775
http://hdl.handle.net/10261/214284
http://hdl.handle.net/10261/214284